Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07009925
What this trial is testing

Phase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC.

Who this might be right for
Squamous Cell Lung Cancer
Jiangsu Cancer Institute & Hospital 38
Testing effectiveness (Phase 2)UnknownNCT03808480
What this trial is testing

Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%

Who this might be right for
Non-small Cell Lung Cancer
National Cancer Center, Korea 22
Early research (Phase 1)Ended earlyNCT03957096
What this trial is testing

A Safety Study of SGN-CD47M in Patients With Solid Tumors

Who this might be right for
Soft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more
Seagen Inc. 16
Not applicableStudy completedNCT04552535
What this trial is testing

A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung

Who this might be right for
Squamous Non-small Cell Lung Cancer
Boehringer Ingelheim 200
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Large-scale testing (Phase 3)Study completedNCT03976362
What this trial is testing

Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)

Who this might be right for
Carcinoma, Squamous Cell, Non-small-cell Lung
Merck Sharp & Dohme LLC 851
Not applicableStudy completedNCT04490564
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Pharmassist Ltd 135
Testing effectiveness (Phase 2)Ended earlyNCT00545948
What this trial is testing

Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Duke University 31
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Testing effectiveness (Phase 2)Study completedNCT00998192
What this trial is testing

REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of the Lung
Oncolytics Biotech 32
Testing effectiveness (Phase 2)UnknownNCT03750916
What this trial is testing

Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Qilu Hospital of Shandong University 46
Large-scale testing (Phase 3)Ended earlyNCT03870152
What this trial is testing

Electrocautery Ablation for the Prevention of Lung Cancer

Who this might be right for
Lung Cancer Squamous Cell
University College, London 13
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Not applicableUnknownNCT01801852
What this trial is testing

Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Chinese PLA General Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT01491633
What this trial is testing

Dasatinib in Advanced Squamous Cell Lung Cancer

Who this might be right for
Squamous Cell Lung Cancer
Dana-Farber Cancer Institute 5
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Testing effectiveness (Phase 2)WithdrawnNCT05234606
What this trial is testing

A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors

Who this might be right for
Urothelial CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer+2 more
Silverback Therapeutics
Early research (Phase 1)Study completedNCT01189968
What this trial is testing

Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
OncoMed Pharmaceuticals, Inc. 50
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Not applicableEnrolling By InvitationNCT06885424
What this trial is testing

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Who this might be right for
Solid Tumor CancerSolid Tumor, Unspecified, AdultColorectal Carcinoma+12 more
A2 Biotherapeutics Inc. 400
Next Page